Related Experiment Videos
Defibrillation electrode configurations developed from cardiac mapping that combine biphasic shocks with sequential
P A Guse1, G P Walcott, D L Rollins
1Department of Medicine, Duke University Medical Center, Durham, NC 27710.
American Heart Journal
|December 1, 1992
Summary
New defibrillation lead configurations using sequential biphasic shocks significantly reduced energy requirements. This approach shows promise for improving transvenous defibrillation efficacy by targeting specific cardiac regions.
Area of Science:
- Cardiovascular research
- Medical device engineering
- Electrophysiology
Background:
- Transvenous defibrillation lead placement is crucial for efficacy.
- Previous configurations showed low potential gradients in the left ventricular apex and right ventricular outflow tract.
- Novel lead configurations are needed to improve defibrillation thresholds.
Purpose of the Study:
- To test 16 new lead configurations incorporating electrodes in the left ventricular apex and right ventricular outflow tract.
- To evaluate the effectiveness of sequential biphasic shocks in reducing defibrillation threshold energy.
- To identify optimal lead configurations for improved transvenous defibrillation.
Main Methods:
- Canine models were used to test 16 novel transvenous defibrillation lead configurations.
- Two sequential biphasic shocks were delivered to different electrode sets.
- Defibrillation threshold energy was compared between new configurations and a standard RV-->P configuration.
Main Results:
- New configurations with sequential biphasic shocks reduced average defibrillation threshold energy by 57% compared to single shocks (p < 0.001).
- The most effective configuration involved sequential shocks from RV-->P to A-->O.
- Single shocks or sequential shocks to the same electrodes were less effective.
Conclusions:
- Sequential biphasic shocks delivered to distinct electrode sets can significantly lower defibrillation thresholds.
- This strategy may enhance defibrillation efficacy by optimizing potential gradients across critical cardiac regions.
- Novel lead configurations hold potential for improved implantable cardioverter-defibrillator therapy.